Belaidi, L.; Wang, P.; Quintin, K.; Durdux, C.; Giroux-Leprieur, E.; Giraud, P.
Impact of Waiting Response Evaluation to First-Line Systemic Therapy before Considering Local Ablative Therapy in Metastatic Non-Small-Cell Lung Cancer. Cancers 2023, 15, 5127.
https://doi.org/10.3390/cancers15215127
AMA Style
Belaidi L, Wang P, Quintin K, Durdux C, Giroux-Leprieur E, Giraud P.
Impact of Waiting Response Evaluation to First-Line Systemic Therapy before Considering Local Ablative Therapy in Metastatic Non-Small-Cell Lung Cancer. Cancers. 2023; 15(21):5127.
https://doi.org/10.3390/cancers15215127
Chicago/Turabian Style
Belaidi, Lahcene, Pascal Wang, Kevin Quintin, Catherine Durdux, Etienne Giroux-Leprieur, and Philippe Giraud.
2023. "Impact of Waiting Response Evaluation to First-Line Systemic Therapy before Considering Local Ablative Therapy in Metastatic Non-Small-Cell Lung Cancer" Cancers 15, no. 21: 5127.
https://doi.org/10.3390/cancers15215127
APA Style
Belaidi, L., Wang, P., Quintin, K., Durdux, C., Giroux-Leprieur, E., & Giraud, P.
(2023). Impact of Waiting Response Evaluation to First-Line Systemic Therapy before Considering Local Ablative Therapy in Metastatic Non-Small-Cell Lung Cancer. Cancers, 15(21), 5127.
https://doi.org/10.3390/cancers15215127
